NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
On Aug. 5, 2020, the Tecan Group and Thermo Fisher Scientific announced a collaboration to enable scaled-up COVID-19…
On Aug. 5, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced that the first 72 participants had been dosed…
On Aug. 5, 2020, Johnson & Johnson announced a $1 billion agreement with the U.S. government for the…
On Aug. 5, 2020, Pfizer Canada and BioNTech SE today announced an agreement with the Government of Canada…
On Aug. 5, 2020, AXIM Biotechnologies announced the development, patent filing and Emergency Use Approval (EUA) filing of…
On Aug. 5, 2020, the Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to the discovery and…
On Aug. 5, 2020, Variation Biotechnologies, an Ottawa-based subsidiary of VBI Vaccines, announced that it had been awarded…
On Aug. 4, 2020, the National Institutes of Health (NIH) announced that patients admitted with COVID-19 at select…
On Aug. 4, 2020, The Centers for Disease Control and Prevention (CDC) anticipates that 2020 will be another…
On Aug. 4, 2020, researchers at The University of Hong Kong (HKUMed) collaborated with researchers at the Institute…
On Aug. 4, 2020, Yale University announced it was among the core partners of the new Center for…
On Aug. 4, 2020, Mateon Therapeutics and Abiogenesis announced they will be working together with Abiogenesis to initiate…
On Aug. 4, 2020, Precipio announced it had completed the internal validation of the U.S. Food and Drug…
On Aug. 4, 2020, Innovation Pharma reported receiving an update from a U.S. Regional Biocontainment Laboratory (RBL) based…
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…
On Aug. 4, 2020, Cocrystal Pharma announced the publication of preclinical animal studies of coronavirus antiviral compounds in…
On Aug. 3, 2020, the University of Oxford and the COVID Symptom Study joined forces to widen access…
On Aug. 3, 2020, members of the COVID R&D Alliance AbbVie, Amgen and Takeda Pharma announced the first…
On Aug. 3, 2020, the La Jolla Institute for Immunology (LJI) announced a $1 million gift from GHR…
On Aug. 3, 2020, Eli Lilly announced the initiation of BLAZE-2, a phase 3 trial studying LY-CoV555 for…
On Aug. 3, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…
On Aug. 3, 2020, Atossa Therapeutics announced that it had received approval from the ethics committee to open…
On Aug. 1, 2020, the Serum Institute of India (SII) got the approval to start human trials in…
On Jul. 31, 2020, the U.S. Food and Drug Administration (FDA) announced it had approved Epidiolex (cannabidiol) [CBD]…
On Jul. 31, 2020, Pfizer and BioNTech announced an agreement with the Ministry of Health, Labour and Welfare…
On Jul. 31, 2020, Sanofi and GSK announced advanced discussions, with the European Commission for the supply of…
On Jul. 31, 2020, Sanofi and GSK announced a collaborative effort with the U.S. government to accelerate the…
On Jul. 31, 2020, researchers from the Pacific Northwest National Laboratory (PNNL) and Oregon Health & Science University…